B-12 injections, phentermine, and non-GLP-1 options Not every patient needs or qualifies for GLP-1 medication
Trafficking to the cell surface of amino acid transporter SLC6A14 upregulated in cancer is controlled by phosphorylation of SEC24C protein by AKT kinase
doi: 10.3389/fimmu.2022.850416 89 BorkumJM
The FDA label for Zepbound includes warnings to monitor patients for depression and suicidal thoughts or behaviors, though clinical trials have not established a definitive causal relationship
These 3.8 million Part D enrollees met the clinical criteria, did not have a diagnosis of type 2 diabetes, OSA, or MASH, or a GLP-1 Part D-covered prescription in 2023, and could be eligible for the Medicare GLP-1 Bridge, assuming no changes in diagnosis or GLP-1 use in Part D in 2026